Search clinical trials for: reverse hybrid therapy
Total 0 results
Nothing found
Sponsors and Collaborators
- Centre Hospitalier de Bastia
- Shamir Optical Industry Ltd
- RINO ZUID
- Research Unit of General Practice, Odense
- Donna Hammond, PhD
- Canadian Hemophilia Society
- Stefania Basili
- Jikei University School of Medicine
- Alfred Hospital Intensive Care Unit Australia
- Jiajie Chen
- Faculdade de Medicina da Universidade do Porto (FMUP)
- Institute of Antibiotics, Huashan Hospital, Fudan University
- IDRI Corporation
- The First Affiliated Hospital of Air Force Medicial University
- InfraScan, Inc.
- Prof. Jürgen Kuschyk, M.D
- Delosis Limited
- University of Natural Resources and Life Sciences, Vienna, Austria
- Cooperative Clinical Drug Research and Development AG (CCDRD AG)
- Deutsche Arthrose-Hilfe
- View Full List
Medical Conditions
- Insulin-Dependent Diabetes Mellitus
- Robot-assisted Laparoscopic Prostatectomy Under General Anesthesia
- Neovascular Age-related Macular Degeneration(nAMD)
- Autosomal Dominant Hypocalcaemia
- Reduction, Weight
- Sepsis and Coagulopathy
- Oxidative Stress in Patient With Haemoglobinopathy and Affect it of Endocrine System
- Incompetence, Functional
- Surgery Induced Tissue Adhesions
- Subgluteal Sciatic Block
- Acute Myocardial Infarction, of Inferolateral Wall
- HIV Related Insulin Resistance
- Ovarian Aging
- Refractory Transformed B-Cell Non-Hodgkin Lymphoma
- Sensory Reconstruction of Digits
- Colonic Adenoma
- Open Reduction and Internal Fixation
- UP in Online Group Format
- Community-Acquired Staphylococcus Aureus
- Asian Consortium
- View Full List
Drug Interventions
- Arm 1 - GEH120714 (18F) Injection
- 13 valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine
- Sorafenib and OSI-906
- Chlorcyclizine HCl
- Domperidone
- LIS 18 U
- Atorvastatin, 10mg, 20mg, 40mg
- Epoetin beta (NeoRecormon®)
- INCB7839
- Propranolol Hydrochloride Extended Release Capsules 160 mg
- HLX23
- Radioligand (11C)AZD2184
- Hypertonic saline
- Moxifloxacin
- Gemcitabine (mg/m²)
- Nanoliposomal Irinotecan
- Rosuvastatin calcium tablets
- Prucalopride
- PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1 inhibitors（pembrolizumab）
- JR-141
- View Full List
CROs by country
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in China
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Italy
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Kenya
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Qatar
- Contract Research Organizations in Sri Lanka
- Contract Research Organizations in Uruguay
- CRO list by country